Sphera Funds Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Sphera Funds Management’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-112,500	Closed	-$3.69M	–	131
2016 Q3	$3.69M	Hold	112,500	–	–	0.6%	43
2016 Q2	$2.81M	Buy	112,500 +50,000	+80%	+$1.35M	0.73%	43
2016 Q1	$1.53M	Sell	62,500 -50,000	-44%	-$1.16M	0.33%	70
2015 Q4	$3.72M	Sell	112,500 -12,500	-10%	-$423K	0.54%	34
2015 Q3	$4.09M	Hold	125,000	–	–	0.52%	37
2015 Q2	$6.62M	Sell	125,000 -25,000	-17%	-$909K	0.65%	28
2015 Q1	$4.33M	Buy	150,000 +50,000	+50%	+$1.37M	0.45%	55
2014 Q4	$2.91M	Sell	100,000 -50,000	-33%	-$897K	0.5%	68
2014 Q3	$1.9M	Buy	+150,000	New	+$2.27M	0.24%	93

Other funds holding ALDR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Sphera Funds Management's ALDR Position: Q4 2016 in Review

Sphera Funds Management sold out of Alder Biopharmaceuticals (ALDR) in Q4 2016, closing a stake of 112,500 shares — an estimated $3.69M sold.

Sphera Funds Management first reported a position in ALDR in Q3 2014 and held it in 9 quarters. The position peaked at $6.62M in Q2 2015. 145 funds tracked by Wall St. Rank hold ALDR as of Q4 2016.

Sphera Funds Management reported no remaining Alder Biopharmaceuticals position as of Q4 2016 after selling out during the quarter.
Sphera Funds Management sold 112,500 Alder Biopharmaceuticals shares in Q4 2016, an estimated $3.69M.
Sphera Funds Management first reported a position in Alder Biopharmaceuticals in Q3 2014 and held it in 9 quarters.
Sphera Funds Management's Alder Biopharmaceuticals position peaked at $6.62M in Q2 2015.
145 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2016.

Based on Sphera Funds Management's 13F filing for Q4 2016, filed 13 Feb 2017.